ChREBP drives diabetic kidney disease, and its inhibition confers renal protection
Proceedings of the National Academy of Sciences, Volume 123, Issue 46, November 2026. SignificanceDiabetic kidney disease is a leading cause of kidney failure, yet current therapies incompletely address the metabolic stress imposed by chronic hyperglycemia.